Global Anti-Obesity Prescription Drugs Market Report 2021
Global Anti-Obesity Prescription Drugs Market Report 2021
The Anti-Obesity Prescription Drugs study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
At the beginning of 2020, COVID-19 disease began to spread around the world, millions of people worldwide were infected with COVID-19 disease, and major countries around the world have implemented foot prohibitions and work stoppage orders. Except for the medical supplies and life support products industries, most industries have been greatly impacted, and Anti-Obesity Prescription Drugs industries have also been greatly affected.
In the past few years, the Anti-Obesity Prescription Drugs market experienced a growth of 15, the global market size of Anti-Obesity Prescription Drugs reached XXX million $ in 2020, of what is about XXX million $ in 2015.
From 2015 to 2019, the growth rate of global Anti-Obesity Prescription Drugs market size was in the range of xxx%. At the end of 2019, COVID-19 began to erupt in China, Due to the huge decrease of global economy; we forecast the growth rate of global economy will show a decrease of about 4%, due to this reason, Anti-Obesity Prescription Drugs market size in 2020 will be XXX with a growth rate of xxx%. This is xxx percentage points lower than in previous years.
As of the date of the report, there have been more than 20 million confirmed cases of CVOID-19 worldwide, and the epidemic has not been effectively controlled. Therefore, we predict that the global epidemic will be basically controlled by the end of 2020 and the global Anti-Obesity Prescription Drugs market size will reach XXX million $ in 2025, with a CAGR of xxx% between 2020-2025.
This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.
Section 1: Free——Definition
Section (2 3): 1200 USD——Manufacturer Detail
VIVUS Inc
Orexigen Therapeutics Inc
Novo Nordisk A/S
F Hoffmann La Roche Ltd
Arena Pharmaceuticals Inc.
GlaxoSmithKline PLC
Roche Holding AG
Merck & Co Inc.
Sun Pharmaceutical Industries Limited
Takeda Pharmaceutical Company Limited
Section 4: 900 USD——Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7): 500 USD——
Product Type Segmentation
Bupropion and Naltrexone
Orlistat
Lorcaserin
Phentermine and Topiramate
Liraglutide
Industry Segmentation
Hospitals Pharmacies
Retail Pharmacies
E-commerce
Channel (Direct Sales, Distributor) Segmentation
Section 8: 400 USD——Trend (2020-2025)
Section 9: 300 USD——Product Type Detail
Section 10: 700 USD——Downstream Consumer
Section 11: 200 USD——Cost Structure
Section 12: 500 USD——Conclusion
Section 1 Anti-Obesity Prescription Drugs Product Definition
Section 2 Global Anti-Obesity Prescription Drugs Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Anti-Obesity Prescription Drugs Shipments
2.2 Global Manufacturer Anti-Obesity Prescription Drugs Business Revenue
2.3 Global Anti-Obesity Prescription Drugs Market Overview
2.4 COVID-19 Impact on Anti-Obesity Prescription Drugs Industry
Section 3 Manufacturer Anti-Obesity Prescription Drugs Business Introduction
3.1 VIVUS Inc Anti-Obesity Prescription Drugs Business Introduction
3.1.1 VIVUS Inc Anti-Obesity Prescription Drugs Shipments, Price, Revenue and Gross profit 2015-2020
3.1.2 VIVUS Inc Anti-Obesity Prescription Drugs Business Distribution by Region
3.1.3 VIVUS Inc Interview Record
3.1.4 VIVUS Inc Anti-Obesity Prescription Drugs Business Profile
3.1.5 VIVUS Inc Anti-Obesity Prescription Drugs Product Specification
3.2 Orexigen Therapeutics Inc Anti-Obesity Prescription Drugs Business Introduction
3.2.1 Orexigen Therapeutics Inc Anti-Obesity Prescription Drugs Shipments, Price, Revenue and Gross profit 2015-2020
3.2.2 Orexigen Therapeutics Inc Anti-Obesity Prescription Drugs Business Distribution by Region
3.2.3 Interview Record
3.2.4 Orexigen Therapeutics Inc Anti-Obesity Prescription Drugs Business Overview
3.2.5 Orexigen Therapeutics Inc Anti-Obesity Prescription Drugs Product Specification
3.3 Novo Nordisk A/S Anti-Obesity Prescription Drugs Business Introduction
3.3.1 Novo Nordisk A/S Anti-Obesity Prescription Drugs Shipments, Price, Revenue and Gross profit 2015-2020
3.3.2 Novo Nordisk A/S Anti-Obesity Prescription Drugs Business Distribution by Region
3.3.3 Interview Record
3.3.4 Novo Nordisk A/S Anti-Obesity Prescription Drugs Business Overview
3.3.5 Novo Nordisk A/S Anti-Obesity Prescription Drugs Product Specification
3.4 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Business Introduction
3.5 Arena Pharmaceuticals Inc. Anti-Obesity Prescription Drugs Business Introduction
3.6 GlaxoSmithKline PLC Anti-Obesity Prescription Drugs Business Introduction
…
Section 4 Global Anti-Obesity Prescription Drugs Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Anti-Obesity Prescription Drugs Market Size and Price Analysis 2015-2020
4.1.2 Canada Anti-Obesity Prescription Drugs Market Size and Price Analysis 2015-2020
4.2 South America Country
4.2.1 South America Anti-Obesity Prescription Drugs Market Size and Price Analysis 2015-2020
4.3 Asia Country
4.3.1 China Anti-Obesity Prescription Drugs Market Size and Price Analysis 2015-2020
4.3.2 Japan Anti-Obesity Prescription Drugs Market Size and Price Analysis 2015-2020
4.3.3 India Anti-Obesity Prescription Drugs Market Size and Price Analysis 2015-2020
4.3.4 Korea Anti-Obesity Prescription Drugs Market Size and Price Analysis 2015-2020
4.4 Europe Country
4.4.1 Germany Anti-Obesity Prescription Drugs Market Size and Price Analysis 2015-2020
4.4.2 UK Anti-Obesity Prescription Drugs Market Size and Price Analysis 2015-2020
4.4.3 France Anti-Obesity Prescription Drugs Market Size and Price Analysis 2015-2020
4.4.4 Italy Anti-Obesity Prescription Drugs Market Size and Price Analysis 2015-2020
4.4.5 Europe Anti-Obesity Prescription Drugs Market Size and Price Analysis 2015-2020
4.5 Other Country and Region
4.5.1 Middle East Anti-Obesity Prescription Drugs Market Size and Price Analysis 2015-2020
4.5.2 Africa Anti-Obesity Prescription Drugs Market Size and Price Analysis 2015-2020
4.5.3 GCC Anti-Obesity Prescription Drugs Market Size and Price Analysis 2015-2020
4.6 Global Anti-Obesity Prescription Drugs Market Segmentation (Region Level) Analysis 2015-2020
4.7 Global Anti-Obesity Prescription Drugs Market Segmentation (Region Level) Analysis
Section 5 Global Anti-Obesity Prescription Drugs Market Segmentation (Product Type Level)
5.1 Global Anti-Obesity Prescription Drugs Market Segmentation (Product Type Level) Market Size 2015-2020
5.2 Different Anti-Obesity Prescription Drugs Product Type Price 2015-2020
5.3 Global Anti-Obesity Prescription Drugs Market Segmentation (Product Type Level) Analysis
Section 6 Global Anti-Obesity Prescription Drugs Market Segmentation (Industry Level)
6.1 Global Anti-Obesity Prescription Drugs Market Segmentation (Industry Level) Market Size 2015-2020
6.2 Different Industry Price 2015-2020
6.3 Global Anti-Obesity Prescription Drugs Market Segmentation (Industry Level) Analysis
Section 7 Global Anti-Obesity Prescription Drugs Market Segmentation (Channel Level)
7.1 Global Anti-Obesity Prescription Drugs Market Segmentation (Channel Level) Sales Volume and Share 2015-2020
7.2 Global Anti-Obesity Prescription Drugs Market Segmentation (Channel Level) Analysis
Section 8 Anti-Obesity Prescription Drugs Market Forecast 2020-2025
8.1 Anti-Obesity Prescription Drugs Segmentation Market Forecast (Region Level)
8.2 Anti-Obesity Prescription Drugs Segmentation Market Forecast (Product Type Level)
8.3 Anti-Obesity Prescription Drugs Segmentation Market Forecast (Industry Level)
8.4 Anti-Obesity Prescription Drugs Segmentation Market Forecast (Channel Level)
Section 9 Anti-Obesity Prescription Drugs Segmentation Product Type
9.1 Bupropion and Naltrexone Product Introduction
9.2 Orlistat Product Introduction
9.3 Lorcaserin Product Introduction
9.4 Phentermine and Topiramate Product Introduction
9.5 Liraglutide Product Introduction
Section 10 Anti-Obesity Prescription Drugs Segmentation Industry
10.1 Hospitals Pharmacies Clients
10.2 Retail Pharmacies Clients
10.3 E-commerce Clients
Section 11 Anti-Obesity Prescription Drugs Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview
Section 12 Conclusion
Chart and Figure
Figure Anti-Obesity Prescription Drugs Product Picture from VIVUS Inc
Chart 2015-2020 Global Manufacturer Anti-Obesity Prescription Drugs Shipments (Units)
Chart 2015-2020 Global Manufacturer Anti-Obesity Prescription Drugs Shipments Share
Chart 2015-2020 Global Manufacturer Anti-Obesity Prescription Drugs Business Revenue (Million USD)
Chart 2015-2020 Global Manufacturer Anti-Obesity Prescription Drugs Business Revenue Share
Chart VIVUS Inc Anti-Obesity Prescription Drugs Shipments, Price, Revenue and Gross profit 2015-2020
Chart VIVUS Inc Anti-Obesity Prescription Drugs Business Distribution
Chart VIVUS Inc Interview Record (Partly)
Figure VIVUS Inc Anti-Obesity Prescription Drugs Product Picture
Chart VIVUS Inc Anti-Obesity Prescription Drugs Business Profile
Table VIVUS Inc Anti-Obesity Prescription Drugs Product Specification
Chart Orexigen Therapeutics Inc Anti-Obesity Prescription Drugs Shipments, Price, Revenue and Gross profit 2015-2020
Chart Orexigen Therapeutics Inc Anti-Obesity Prescription Drugs Business Distribution
Chart Orexigen Therapeutics Inc Interview Record (Partly)
Figure Orexigen Therapeutics Inc Anti-Obesity Prescription Drugs Product Picture
Chart Orexigen Therapeutics Inc Anti-Obesity Prescription Drugs Business Overview
Table Orexigen Therapeutics Inc Anti-Obesity Prescription Drugs Product Specification
Chart Novo Nordisk A/S Anti-Obesity Prescription Drugs Shipments, Price, Revenue and Gross profit 2015-2020
Chart Novo Nordisk A/S Anti-Obesity Prescription Drugs Business Distribution
Chart Novo Nordisk A/S Interview Record (Partly)
Figure Novo Nordisk A/S Anti-Obesity Prescription Drugs Product Picture
Chart Novo Nordisk A/S Anti-Obesity Prescription Drugs Business Overview
Table Novo Nordisk A/S Anti-Obesity Prescription Drugs Product Specification
3.4 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Business Introduction
…
Chart United States Anti-Obesity Prescription Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart United States Anti-Obesity Prescription Drugs Sales Price ($/Unit) 2015-2020
Chart Canada Anti-Obesity Prescription Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Canada Anti-Obesity Prescription Drugs Sales Price ($/Unit) 2015-2020
Chart South America Anti-Obesity Prescription Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart South America Anti-Obesity Prescription Drugs Sales Price ($/Unit) 2015-2020
Chart China Anti-Obesity Prescription Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart China Anti-Obesity Prescription Drugs Sales Price ($/Unit) 2015-2020
Chart Japan Anti-Obesity Prescription Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Japan Anti-Obesity Prescription Drugs Sales Price ($/Unit) 2015-2020
Chart India Anti-Obesity Prescription Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart India Anti-Obesity Prescription Drugs Sales Price ($/Unit) 2015-2020
Chart Korea Anti-Obesity Prescription Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Korea Anti-Obesity Prescription Drugs Sales Price ($/Unit) 2015-2020
Chart Germany Anti-Obesity Prescription Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Germany Anti-Obesity Prescription Drugs Sales Price ($/Unit) 2015-2020
Chart UK Anti-Obesity Prescription Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart UK Anti-Obesity Prescription Drugs Sales Price ($/Unit) 2015-2020
Chart France Anti-Obesity Prescription Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart France Anti-Obesity Prescription Drugs Sales Price ($/Unit) 2015-2020
Chart Italy Anti-Obesity Prescription Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Italy Anti-Obesity Prescription Drugs Sales Price ($/Unit) 2015-2020
Chart Europe Anti-Obesity Prescription Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Europe Anti-Obesity Prescription Drugs Sales Price ($/Unit) 2015-2020
Chart Middle East Anti-Obesity Prescription Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Middle East Anti-Obesity Prescription Drugs Sales Price ($/Unit) 2015-2020
Chart Africa Anti-Obesity Prescription Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Africa Anti-Obesity Prescription Drugs Sales Price ($/Unit) 2015-2020
Chart GCC Anti-Obesity Prescription Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart GCC Anti-Obesity Prescription Drugs Sales Price ($/Unit) 2015-2020
Chart Global Anti-Obesity Prescription Drugs Market Segmentation (Region Level) Sales Volume 2015-2020
Chart Global Anti-Obesity Prescription Drugs Market Segmentation (Region Level) Market size 2015-2020
Chart Anti-Obesity Prescription Drugs Market Segmentation (Product Type Level) Volume (Units) 2015-2020
Chart Anti-Obesity Prescription Drugs Market Segmentation (Product Type Level) Market Size (Million $) 2015-2020
Chart Different Anti-Obesity Prescription Drugs Product Type Price ($/Unit) 2015-2020
Chart Anti-Obesity Prescription Drugs Market Segmentation (Industry Level) Market Size (Volume) 2015-2020
Chart Anti-Obesity Prescription Drugs Market Segmentation (Industry Level) Market Size (Share) 2015-2020
Chart Anti-Obesity Prescription Drugs Market Segmentation (Industry Level) Market Size (Value) 2015-2020
Chart Global Anti-Obesity Prescription Drugs Market Segmentation (Channel Level) Sales Volume (Units) 2015-2020
Chart Global Anti-Obesity Prescription Drugs Market Segmentation (Channel Level) Share 2015-2020
Chart Anti-Obesity Prescription Drugs Segmentation Market Forecast (Region Level) 2020-2025
Chart Anti-Obesity Prescription Drugs Segmentation Market Forecast (Product Type Level) 2020-2025
Chart Anti-Obesity Prescription Drugs Segmentation Market Forecast (Industry Level) 2020-2025
Chart Anti-Obesity Prescription Drugs Segmentation Market Forecast (Channel Level) 2020-2025
Chart Bupropion and Naltrexone Product Figure
Chart Bupropion and Naltrexone Product Advantage and Disadvantage Comparison
Chart Orlistat Product Figure
Chart Orlistat Product Advantage and Disadvantage Comparison
Chart Lorcaserin Product Figure
Chart Lorcaserin Product Advantage and Disadvantage Comparison
Chart Phentermine and Topiramate Product Figure
Chart Phentermine and Topiramate Product Advantage and Disadvantage Comparison
Chart Liraglutide Product Figure
Chart Liraglutide Product Advantage and Disadvantage Comparison
Chart Hospitals Pharmacies Clients
Chart Retail Pharmacies Clients
Chart E-commerce Clients
Research Methodology:
Anti-Obesity Prescription Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|